Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia
Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
A 48-Week Prospective, Double-Blinded, Randomized, Cross-over design in Multicenter Study of,
250 unit of Abobotulinum Toxin Type A (Dysport) and 50 unit of Neubotulinum Toxin Type A
(Neuronox) injection for Cervical Dystonia in patient diagnosed with cervical dystonia
according to clinical diagnosis. It was designed to evaluate the efficacy, safety,
tolerability, quality of life and the comparesion the improvement after treatment by of
Abobotulinum Toxin Type A (Dysport) injection versus Neubotulinum Toxin Type A
(Neuronox)Injection.
Phase:
Phase 3
Details
Lead Sponsor:
Rajavithi Hospital
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A onabotulinumtoxinA